Replies to post #137214 on Biotech Values

[DewDiligence]

GILD—GS-7977 gets straight A's for efficacy, tolerability, and safety but now the strength of the drug’s resistance profile when used orally in combination with ribavirin is in question.

It’s a little early to say that the resistance profile per se is the main culprit in the data reported today. This was asked and answered on the CC.

[GrthzGd]

ACHN, another protease inhibitor, up 22% AIW; GILD dip result? (Yours truly bot 2k shares yesterday on dumb luck--thx everyone!)